DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced that VAYA Pharma, a specialty medical food division of Enzymotec Ltd. (NASDAQ:ENZY), has adopted IMS Health's Nexxus™ Mobile Intelligence CRM solution to support the successful expansion of VAYA's sales team and commercial operations. Designed for the life sciences market, this mobile field solution seamlessly integrates IMS Health, industry data and VAYA intelligence with decision-support tools to fuel more coordinated and productive customer engagements.
VAYA Pharma develops, manufactures and markets innovative lipid-based treatments to address health conditions associated with nutritional imbalances. VAYA Pharma’s current medical food portfolio addresses three therapeutic segments: ADHD with Vayarin®, Early Memory Impairment with Vayacog® and Hypertriglyceridemia with Vayarol®.
“This is an exciting time for VAYA and it’s essential we have the appropriate technology in place in order to successfully execute our commercial growth strategy,” said Rob Crim, CEO, VAYA Pharma. “We selected IMS Health as a partner because of its deep pharma and healthcare expertise, and its business-enabled technology solutions are purpose-built for the life sciences.”
By curating insights, Nexxus MI helps commercial teams tailor precision conversations across customers’ preferred communications channels. The mobile-optimized solution empowers field teams to interact with healthcare professionals on any digital device. Nexxus MI makes it fast and simple for sales representatives to capture details of customer interactions directly from their tablets in the field. In addition, most Nexxus MI functions are available offline, which is beneficial to customer-facing professionals who often work in locations where connectivity may not be available.
Nexxus MI’s highly intuitive interface and usability were key factors in VAYA’s decision to partner with IMS Health. Compared to the prior CRM system, Nexxus MI has achieved higher utilization rates among VAYA’s sales representatives. The IMS Health cloud solution also benefits VAYA’s home office by offering robust account management capabilities while significantly reducing administration and maintenance requirements.
“We’re very pleased to support VAYA as it expands its commercial operations to reflect the continued increased adoption of the company's products by healthcare providers and their patients,” said Tal Rosenberg, general manager, Technology Solutions, IMS Health. “With Nexxus MI, VAYA’s sales force has the pertinent tools and insight it needs to deliver the right messages to the right healthcare providers at the right time, which is critical for the advancement of patient care and health outcomes.”
Nexxus MI is part of the Nexxus Commercial Application Suite, which brings together the most complete and fully connected set of applications across the commercial continuum, from marketing campaign management and social media monitoring to customer engagement, sales operations and performance management. For more information, visit www.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.